---
title: Gramicidin + Neomycin + Triamcinolone
description: >-
  This combination medication is prescribed for the treatment of superficial
  bacterial and fungal infections of the skin and ear, particularly otitis
  externa (outer ear infection). It is also used for corticosteroid-responsive
  dermatoses (skin conditions that respond to steroids) with secondary inf...
is_banned: false
lastModified: '2025-09-22T17:22:09.347Z'
faqs:
  - q: >-
      What is the recommended dosage for Gramicidin + Neomycin +
      Triamcinolone?**


      **A:** The standard dosage is to apply a thin layer to the affected skin
      area 2-3 times daily. For otic use, instill 2-3 drops into the ear canal
      2-3 times daily. Dosage adjustments may be necessary for pediatric,
      elderly, or patients with renal/hepatic impairment.
    a: >-
      A:** The standard dosage is to apply a thin layer to the affected skin
      area 2-3 times daily. For otic use, instill 2-3 drops into the ear canal
      2-3 times daily. Dosage adjustments may be necessary for pediatric,
      elderly, or patients with renal/hepatic impairment.
  - q: >-
      What are the common side effects of this medication?**


      **A:** Common side effects include burning, itching, irritation, dryness,
      and redness at the application site.
    a: >-
      A:** Common side effects include burning, itching, irritation, dryness,
      and redness at the application site.
  - q: >-
      Can this medication be used if I have a perforated eardrum?**


      **A:** No. Otic formulations of this medication are contraindicated in
      patients with a perforated eardrum.
    a: >-
      A:** No. Otic formulations of this medication are contraindicated in
      patients with a perforated eardrum.
  - q: >-
      Can this medication be used during pregnancy or while breastfeeding?**


      **A:**  Use with caution during pregnancy and breastfeeding, only if the
      potential benefits outweigh the potential risks to the fetus or infant. 
      Consult with a healthcare professional.
    a: >-
      A:**  Use with caution during pregnancy and breastfeeding, only if the
      potential benefits outweigh the potential risks to the fetus or infant. 
      Consult with a healthcare professional.
  - q: >-
      What should I do if my symptoms do not improve after using this
      medication?**


      **A:** If symptoms do not improve after a week of treatment, consult a
      physician. The infection may be resistant to the antibiotics in the
      medication, or there may be an underlying condition requiring different
      treatment.
    a: >-
      A:** If symptoms do not improve after a week of treatment, consult a
      physician. The infection may be resistant to the antibiotics in the
      medication, or there may be an underlying condition requiring different
      treatment.
  - q: >-
      Can I use this medication on my face?**


      **A:** Use with caution on the face, as prolonged use can lead to skin
      thinning and other side effects.
    a: >-
      A:** Use with caution on the face, as prolonged use can lead to skin
      thinning and other side effects.
  - q: >-
      What are the potential drug interactions with this combination
      medication?**


      **A:** Be cautious when using this medication concomitantly with other
      topical corticosteroids, ototoxic drugs (especially aminoglycosides), and
      nephrotoxic drugs.
    a: >-
      A:** Be cautious when using this medication concomitantly with other
      topical corticosteroids, ototoxic drugs (especially aminoglycosides), and
      nephrotoxic drugs.
  - q: >-
      Are there any long-term side effects associated with this medication?**


      **A:** Prolonged use of this medication, especially with high potency
      formulations or under occlusive dressings, can lead to skin thinning,
      stretch marks, and excessive hair growth.  Systemic absorption, though
      limited with topical use, may potentially result in Cushing syndrome or
      adrenal suppression with prolonged use.
    a: >-
      A:** Prolonged use of this medication, especially with high potency
      formulations or under occlusive dressings, can lead to skin thinning,
      stretch marks, and excessive hair growth.  Systemic absorption, though
      limited with topical use, may potentially result in Cushing syndrome or
      adrenal suppression with prolonged use.
  - q: >-
      Can this be used on open wounds?**


      **A:** This medication should not be used on open wounds or burns to avoid
      excessive systemic absorption.
    a: >-
      A:** This medication should not be used on open wounds or burns to avoid
      excessive systemic absorption.
---
## **Usage**

This combination medication is prescribed for the treatment of superficial bacterial and fungal infections of the skin and ear, particularly otitis externa (outer ear infection). It is also used for corticosteroid-responsive dermatoses (skin conditions that respond to steroids) with secondary infection.

**Pharmacological Classification:**

* **Gramicidin:** Polypeptide antibiotic
* **Neomycin:** Aminoglycoside antibiotic
* **Triamcinolone:** Corticosteroid

**Mechanism of Action:**

This medication combines an anti-inflammatory, antibacterial, and antifungal agent. Triamcinolone reduces inflammation, itching, and swelling. Neomycin and gramicidin inhibit bacterial growth, while nystatin inhibits the growth of fungi and yeasts.

## **Alternate Names**

This combination medication is often referred to as a topical triple antibiotic with a corticosteroid. No internationally recognized non-proprietary name (INN) exists for this combination.

**Brand Names:**

Examples of brand names include Kenacomb, Otocomb, Viaderm KC, Celsus. Brand names may vary regionally.

## **How It Works**

**Pharmacodynamics:**

* **Triamcinolone acetonide:** Exerts its anti-inflammatory, antipruritic, and vasoconstrictive effects by binding to glucocorticoid receptors. This leads to changes in gene expression, inhibiting inflammatory mediators like prostaglandins and leukotrienes.
* **Neomycin and Gramicidin:** Inhibit bacterial protein synthesis by binding to the bacterial ribosome. Neomycin is effective against many gram-negative bacteria, while gramicidin is active against gram-positive bacteria.
* **Nystatin (when present):** Binds to ergosterol, a component of fungal cell membranes, causing membrane disruption and fungal cell death.

**Pharmacokinetics:**

Topical application primarily limits systemic absorption. However, some absorption can occur, particularly with prolonged use, occlusive dressings, or application to damaged skin. Triamcinolone is metabolized in the liver and excreted in the urine and bile.  Neomycin and gramicidin have limited systemic absorption but can accumulate with impaired renal function. Nystatin is minimally absorbed from the GI tract following ingestion, and absorption following topical application is negligible.


**Elimination Pathways:**

* **Triamcinolone acetonide:** Primarily hepatic metabolism, followed by renal and biliary excretion.
* **Neomycin and Gramicidin:** Primarily renal excretion.
* **Nystatin:** Mostly excreted unchanged in the feces.


## **Dosage**

### **Standard Dosage**

#### **Adults:**

Apply a thin layer to the affected area 2-3 times daily. For otic use, instill 2-3 drops into the ear canal 2-3 times daily.

#### **Children:**

Apply sparingly to the affected area 2-3 times daily. Pediatric dosage should be determined based on the child's age, weight, and specific condition. 

#### **Special Cases:**

* **Elderly Patients:** Use sparingly for short durations due to increased risk of skin thinning.
* **Patients with Renal Impairment:**  Caution is advised with neomycin and gramicidin due to potential nephrotoxicity.  
* **Patients with Hepatic Dysfunction:** Dosage adjustment of triamcinolone may be needed.
* **Patients with Comorbid Conditions:** Use with caution in patients with diabetes or other conditions that might be exacerbated by corticosteroids.



### **Clinical Use Cases**

Dosage guidelines for specific clinical settings are the same as the standard dosage.


### **Dosage Adjustments**

Dosage adjustments should be made based on individual patient factors like age, the extent of the affected area, and the severity of the condition. Close monitoring is recommended for patients with renal or hepatic impairment.


## **Side Effects**


### **Common Side Effects**

* Burning
* Itching
* Irritation
* Dryness
* Redness

### **Rare but Serious Side Effects**

* Allergic reactions (rash, hives, swelling)
* Hearing loss (with otic use)
* Skin atrophy
* Telangiectasia (spider veins)
* Cushing's syndrome (with prolonged use)
* Nephrotoxicity (with neomycin)
* Ototoxicity (with neomycin and gramicidin, especially with a perforated eardrum)

### **Long-Term Effects**

* Skin thinning
* Stretch marks
* Hypertrichosis (excessive hair growth)



## **Contraindications**

* Hypersensitivity to any of the components
* Viral skin infections (herpes simplex, varicella, vaccinia)
* Tuberculous lesions
* Perforated eardrum (for otic preparations)
* Rosacea, acne, perioral dermatitis (for topical preparations)


## **Drug Interactions**

* Other topical corticosteroids: Increased risk of systemic side effects
* Ototoxic drugs: Increased risk of hearing loss with concomitant use (especially aminoglycosides)
* Nephrotoxic drugs: Increased risk of kidney damage (especially aminoglycosides)



## **Pregnancy and Breastfeeding**

Topical application limits systemic absorption. However, use during pregnancy and breastfeeding should be only if clearly needed and under close medical supervision.  Neomycin and other aminoglycosides can cross the placenta and may cause fetal harm.  Triamcinolone is classified as Pregnancy Category C, which means that risk cannot be ruled out. It is unknown whether topical application results in sufficient systemic absorption to produce detectable quantities in breast milk.  Systemically administered corticosteroids are secreted into breast milk, but the effect on the infant is unknown. Consult with a healthcare professional for further discussion about using this medicine when pregnant or breastfeeding.



## **Drug Profile Summary**

* **Mechanism of Action:**  Triamcinolone: Anti-inflammatory, antipruritic, vasoconstrictive. Neomycin and Gramicidin: Antibacterial. Nystatin: Antifungal.
* **Side Effects:** Burning, itching, irritation, dryness, redness. Rarely: allergic reactions, hearing loss, skin atrophy, telangiectasia, Cushing's syndrome (with prolonged use).
* **Contraindications:** Hypersensitivity, viral skin infections, perforated eardrum (for otic use).
* **Drug Interactions:** Other topical corticosteroids, ototoxic drugs, nephrotoxic drugs.
* **Pregnancy & Breastfeeding:** Use with caution if benefits outweigh risks.  
* **Dosage:** Apply a thin layer 2-3 times/day. Otic: 2-3 drops 2-3 times/day.
* **Monitoring Parameters:**  For prolonged use: monitor for signs of Cushing's syndrome, adrenal suppression, or skin atrophy. Monitor renal function in patients with pre-existing renal impairment. With otic use, monitor for hearing loss, especially if the tympanic membrane is perforated.




## **Popular Combinations**

This medication is typically formulated as a combination product and not usually combined with other medications.




## **Precautions**

* Avoid prolonged use, especially on the face, groin, or axillae.
* Do not use occlusive dressings unless directed by a physician.
* Discontinue use if irritation or sensitization occurs.
* Avoid contact with eyes and mucous membranes.
* Monitor patients with renal or hepatic impairment closely.

## **FAQs (Frequently Asked Questions)**



### **Q1: What is the recommended dosage for Gramicidin + Neomycin + Triamcinolone?**

**A:** The standard dosage is to apply a thin layer to the affected skin area 2-3 times daily. For otic use, instill 2-3 drops into the ear canal 2-3 times daily. Dosage adjustments may be necessary for pediatric, elderly, or patients with renal/hepatic impairment.

### **Q2: What are the common side effects of this medication?**

**A:** Common side effects include burning, itching, irritation, dryness, and redness at the application site.

### **Q3:  Can this medication be used if I have a perforated eardrum?**

**A:** No. Otic formulations of this medication are contraindicated in patients with a perforated eardrum.

### **Q4:  Can this medication be used during pregnancy or while breastfeeding?**

**A:**  Use with caution during pregnancy and breastfeeding, only if the potential benefits outweigh the potential risks to the fetus or infant.  Consult with a healthcare professional.

### **Q5: What should I do if my symptoms do not improve after using this medication?**

**A:** If symptoms do not improve after a week of treatment, consult a physician. The infection may be resistant to the antibiotics in the medication, or there may be an underlying condition requiring different treatment.

### **Q6: Can I use this medication on my face?**

**A:** Use with caution on the face, as prolonged use can lead to skin thinning and other side effects.

### **Q7: What are the potential drug interactions with this combination medication?**

**A:** Be cautious when using this medication concomitantly with other topical corticosteroids, ototoxic drugs (especially aminoglycosides), and nephrotoxic drugs.


### **Q8: Are there any long-term side effects associated with this medication?**

**A:** Prolonged use of this medication, especially with high potency formulations or under occlusive dressings, can lead to skin thinning, stretch marks, and excessive hair growth.  Systemic absorption, though limited with topical use, may potentially result in Cushing syndrome or adrenal suppression with prolonged use.


### **Q9: Can this be used on open wounds?**

**A:** This medication should not be used on open wounds or burns to avoid excessive systemic absorption.

